BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 37108425)

  • 1. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
    Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer.
    Sun J; Yuan J
    Bioengineered; 2022 Mar; 13(3):7579-7591. PubMed ID: 35264061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers.
    Korbecki J; Bosiacki M; Barczak K; Łagocka R; Chlubek D; Baranowska-Bosiacka I
    Cells; 2023 May; 12(10):. PubMed ID: 37408240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.
    Wallace AE; Sales KJ; Catalano RD; Anderson RA; Williams AR; Wilson MR; Schwarze J; Wang H; Rossi AG; Jabbour HN
    Cancer Res; 2009 Jul; 69(14):5726-33. PubMed ID: 19549892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.
    Korbecki J; Bosiacki M; Szatkowska I; Kupnicka P; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.
    Korbecki J; Bosiacki M; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
    Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
    PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
    Li Z; Huang N; Zhang W; Li L
    Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
    Ji HZ; Liu B; Ren M; Li S; Zheng JF; Liu TY; Yu HH; Sun Y
    Expert Rev Clin Immunol; 2024 May; 20(5):559-569. PubMed ID: 38224014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
    Park GY; Pathak HB; Godwin AK; Kwon Y
    Cell Oncol (Dordr); 2021 Feb; 44(1):77-92. PubMed ID: 32910411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
    Bolitho C; Hahn MA; Baxter RC; Marsh DJ
    Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.
    Cheng WL; Wang CS; Huang YH; Tsai MM; Liang Y; Lin KH
    Ann Oncol; 2011 Oct; 22(10):2267-76. PubMed ID: 21343381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer.
    Lv M; Xu Y; Tang R; Ren J; Shen S; Chen Y; Liu B; Hou Y; Wang T
    Mol Cancer Ther; 2014 Dec; 13(12):3152-62. PubMed ID: 25349304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
    Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis.
    Gavamukulya Y; Maina EN; El-Shemy HA; Meroka AM; Kangogo GK; Magoma G; Wamunyokoli F
    Tumour Biol; 2021; 43(1):37-55. PubMed ID: 33935122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer.
    Miyake M; Lawton A; Goodison S; Urquidi V; Rosser CJ
    Pathol Res Pract; 2014 Feb; 210(2):74-8. PubMed ID: 24252309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.